Alan Chiu
Alan Chiu
@chiuonscience.bsky.social
Scientist interested in diabetes (especially Type 1), organoids, islets, oncology, and tissue engineering … also unhealthy devoted to the Oscar campaigns of actresses Views are my own and do not represent BreakthroughT1D
274 followers132 following19 posts
Several BreakthroughT1D funding opportunities available 1) Advancing GRS, especially in non-European backgrounds 2) Early detection in adult-onset T1D 3) Tech for scaling manufactured islets Feel free to reach out with questions. Open to industry and academia #funding #grants #T1D
Alan Chiu reposted
Are you interested in developing a research programme in cell biology of diabetes? Do you work in pancreatic islets and/or other metabolically relevant cells? We have a Lectureship post opening in our Section @imperialcollegeldn.bsky.social Apply by 25th March: www.imperial.ac.uk/jobs/search-...
How cool, the Clevers lab able to generate fetal pancreatic organoids with all 3 lineages including insulin+ endocrine cells. Will be a really powerful tool for understanding and modeling pancreatic development and dysfunction.
Really encouraging results! T1D patients on tirzepatide lost an average of 10% of their bw without an increase in DKA or severe hypoglycemic events … looking forward to future studies with readouts on its effect on CVD www.sciencedirect.com/science/arti...
Really interesting read! To me, vascularization of grafts is the least developed aspect of islet transplantation and studies like this are helpful for understanding what exactly is it we're trying to build
Check out our review led by the amazing @rlhull-meichle.bsky.social on the role of pancreatic microvascualture in health and disease and beta cell replacement therapies: journals.sagepub.com/doi/full/10....
Alan Chiu reposted
Stem cell-derived islets engineered to express EGFRt were targeted by CAR-Treg cells to suppress innate and adaptive immune responses, which may prevent immune rejection for #T1D cell therapy. Congrats to the Ferreira and Russ teams! www.cell.com/cell-reports... #regenerativemedicine
Alan Chiu reposted
Thrilled to share one of our biggest discoveries: “Inceptor binds to and directs insulin towards lysosomal degradation in beta cells”. doi.org/10.1038/s422... A tremendous collaborative effort led by JohannaSiehler, Sara Bilekova and other members of the Lickert lab @heikolickert.bsky.social
Alan Chiu reposted
Check out this fantastic work by our lab alumnus Kai Wang: Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery. Now out in Cell Stem Cell www.cell.com/cell-stem-ce...
Alan Chiu reposted
Great to see this update by Kidney Research UK on all things #Diabetic #Kidneydisease in 2024. Special thanks for highlighting the work of our #PhD student Paige on targetting cell senescence in diabetic nephropathy 👩🔬🥼🧪..Full details 👇👇 #NephSky #diabetes www.kidneyresearchuk.org/2024/10/24/d...
Cell therapy manufacturing hubs like the one being built on Long Island are going to be huge for access (and economically) as CAR-T and other treatments expand beyond oncology and become more mainstream, especially as the hypoimmune CAR-T efforts seem to be struggling
The counterattack An immune cell treatment that fights cancer is now taking aim at autoimmune disease 🔗https://www.science.org/content/article/breakthrough-cancer-immunotherapy-now-taking-aim-autoimmune-disease h/t @kellyservick.bsky.social & Jennifer Couzin-Frankel👨🔬
Alan Chiu reposted
Our new work! We show that T cell cross-reactivity can be reduced without modifying the TCR itself (by dramatically enhancing antigen discrimination). Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors www.biorxiv.org/content/10.1...
⭐💸 Funding Opps 💸⭐ Two new calls from BreakthroughT1D The first is for advancing technologies that support engraftment of transplants The second looks at common mechanisms for autoimmune disease Feel free to reach out with questions #funding #t1d #grants www.breakthrought1d.org/explore-rese...
Alan Chiu reposted
Glucagon-like Peptide-1 Receptor Agonists: New Evidence of Kidney and Cardiovascular Protection From the FLOW and SELECT Trials 👇👇👨🔬🧪🥼 #cardiacsky #nephsky #medsky #cardiovascular #kidneydisease #Type2diabetes #semaglutide www.ajkd.org/article/S027...
Another exciting trial result for GLP-1s (tirzepatide), this time for HFpEF Add that to the growing list of secondary benefits it could have for T1D patients as an adjuvant to insulin www.nejm.org/doi/full/10....
You are up to date.